- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MDCO Market Currents
more »
-
April 25 Medicines Company (MDCO): Q1 EPS of $0.27 beats by $0.13. Revenue of $126.6M (+12.9% Y/Y) beats by $2.6M. (PR)
Comment![Earnings, Healthcare]
MDCO in Focus
more »
MDCO Related Articles
more »
MDCO News
more »
-
at MarketWatch.com (Feb 22, 2012)
MDCO Press Releases and Filings
more »
-
Marketwire (May 8, 2012)
-
Marketwire (Apr 30, 2012)
-
Marketwire (Apr 25, 2012)
-
Marketwire (Apr 10, 2012)
-
Marketwire (Jan 23, 2012)
MDCO Latest Transcript
more »
-
Mon, May 7Popular searches: Cleviprex.
MDCO Cramer
more »
Currently, there are no Cramer articles on MDCO.
MDCO Instablog posts
more »
MDCO vs. ETF Alternatives
Company Description
Currently, there's no company description for MDCO.
